Gilead Sciences Stock Target Price and Analyst Consensus
| GILD Stock | USD 111.53 1.58 1.44% |
The current analyst and expert consensus on Gilead Sciences is Strong Buy with 11 hold recommendations. The current projected Gilead Sciences target price consensus is 99.96 with 28 analyst opinions. One of the most common ways Gilead Sciences analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Gilead Sciences vendors, executives, and/or customers. Gilead Sciences recommendation module provides expert sentiment on the projected Gilead Sciences target price to derive its highest and lowest estimates based on target price standard deviation of 1.5637.
Lowest Forecast 90.96 | Highest Forecast 110.95 | Target Price 99.96 |
Gilead |
It's important to approach Gilead Sciences' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Gilead Sciences Target Price Consensus
Gilead target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Gilead Sciences' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 28 | Strong Buy |
Most Gilead analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Gilead stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Gilead Sciences, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationGilead Sciences Target Price Projection
Gilead Sciences' current and average target prices are 111.53 and 99.96, respectively. The current price of Gilead Sciences is the price at which Gilead Sciences is currently trading. On the other hand, Gilead Sciences' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Gilead Sciences Market Quote on 25th of February 2025
Target Price
Analyst Consensus On Gilead Sciences Target Price
Gilead Sciences Analyst Ratings
Gilead Sciences' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Gilead Sciences stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Gilead Sciences' financials, market performance, and future outlook by experienced professionals. Gilead Sciences' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Gilead Sciences price targets
Gilead Sciences' stock target price is an estimate of its future price, usually made by analysts. Using Gilead Sciences' target price to determine if it is a suitable investment can be done through the following steps:- Look at Gilead Sciences' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Gilead Sciences' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Gilead Sciences Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Gilead Sciences is a key component of Gilead Sciences valuation and have some predictive power on the future returns of a Gilead Sciences.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Artificial Intelligence Invested few shares | |
 | Warren Buffett Holdings Invested over 30 shares | |
 | Driverless Cars Invested over 60 shares | |
 | Banking Invested over 30 shares | |
 | Cash Cows Invested few shares | |
 | Momentum Invested over 60 shares | |
 | Blockchain Invested few shares | |
 | Automobiles and Trucks Invested over 300 shares | |
 | Hedge Favorites Invested few shares | |
 | Manufacturing Invested over 30 shares | |
Check out Macroaxis Advice on Gilead Sciences to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Please note, the presentation of Gilead Sciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Gilead Sciences' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Gilead Sciences' management manipulating its earnings.